219 related articles for article (PubMed ID: 29396855)
1. Use of a novel 1-hour protocol for rapid frozen section immunocytochemistry, in a case of squamous cell carcinoma treated with Mohs micrographic surgery.
Sinha K; Ali F; Orchard G; Rickaby W; Shams M; Mallipeddi R; Patalay R
Clin Exp Dermatol; 2018 Jun; 43(4):454-457. PubMed ID: 29396855
[TBL] [Abstract][Full Text] [Related]
2. Pan-cytokeratin markers for rapid frozen section immunocytochemistry from head and facial Mohs cases of basal cell carcinoma: a comparison and evaluation to determine the marker of choice.
Orchard GE; Wojcik K; Shams F; Georgaki E; Quaye CJ; Fernando P; Torres J; Ismail F; Shams M
Br J Biomed Sci; 2015; 72(2):61-6. PubMed ID: 26126321
[TBL] [Abstract][Full Text] [Related]
3. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
4. Dual Immunostaining With SOX10 and AE1/AE3 to Confirm Perineural Invasion on Mohs Sections.
Donaldson MR; Weber A
J Drugs Dermatol; 2019 Mar; 18(3):262-264. PubMed ID: 30909330
[TBL] [Abstract][Full Text] [Related]
5. Low recurrence rates for challenging squamous cell carcinomas using Mohs micrographic surgery with AE1/AE3 cytokeratin immunostaining.
Aizman L; Miller CJ; Perz AM; Lukowiak TM; Cohen OG; Bean E; Hitchner MK; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; Cohen JV; Miura JT; Sobanko JF
J Am Acad Dermatol; 2021 May; 84(5):1453-1455. PubMed ID: 32622892
[No Abstract] [Full Text] [Related]
6. Mohs micrographic surgery concordance between Mohs surgeons and dermatopathologists.
Semkova K; Mallipeddi R; Robson A; Palamaras I
Dermatol Surg; 2013 Nov; 39(11):1648-52. PubMed ID: 24581313
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma.
Smeets NW; Stavast-Kooy AJ; Krekels GA; Daemen MJ; Neumann HA
Dermatol Surg; 2003 Apr; 29(4):375-7. PubMed ID: 12656816
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation.
Jimenez FJ; Grichnik JM; Buchanan MD; Clark RE
J Am Acad Dermatol; 1995 Jan; 32(1):89-94. PubMed ID: 7529778
[TBL] [Abstract][Full Text] [Related]
9. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers.
Ebede TL; Lee EH; Dusza SW; Busam KJ; Nehal KS
Dermatol Surg; 2012 Oct; 38(10):1631-8. PubMed ID: 22958072
[TBL] [Abstract][Full Text] [Related]
11. Mohs frozen tissue sections in comparison to similar paraffin-embedded tissue sections in identifying perineural tumor invasion in cutaneous squamous cell carcinoma.
Green JS; Tournas JA; Allen EJ; Youker SR; Fosko SW
J Am Acad Dermatol; 2012 Jul; 67(1):113-21. PubMed ID: 22533992
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic pitfalls of Mohs micrographic surgery and a review of tumor histology.
França K; Alqubaisy Y; Hassanein A; Nouri K; Lotti T
Wien Med Wochenschr; 2018 Jun; 168(9-10):218-227. PubMed ID: 27832425
[TBL] [Abstract][Full Text] [Related]
13. Frozen-Section Tissue Processing in Mohs Surgery.
Aslam A; Aasi SZ
Dermatol Surg; 2019 Dec; 45 Suppl 2():S57-S69. PubMed ID: 31764292
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review.
Kyllo RL; Staser KW; Rosman I; Council ML; Hurst EA
J Am Acad Dermatol; 2019 Aug; 81(2):541-547. PubMed ID: 31230975
[TBL] [Abstract][Full Text] [Related]
15. Lymphoepithelioma-like carcinoma of the skin treated with Mohs micrographic surgery in combination with immune staining for cytokeratins.
Jimenez F; Clark RE; Buchanan MD; Kamino H
J Am Acad Dermatol; 1995 May; 32(5 Pt 2):878-81. PubMed ID: 7536761
[TBL] [Abstract][Full Text] [Related]
16. High-risk squamous cell carcinoma masquerading as dense inflammation on Mohs frozen sections.
Leow LJ
Australas J Dermatol; 2018 Aug; 59(3):214-216. PubMed ID: 29064089
[TBL] [Abstract][Full Text] [Related]
17. Immunostaining melanoma frozen sections: the 1-hour protocol.
Bricca GM; Brodland DG; Zitelli JA
Dermatol Surg; 2004 Mar; 30(3):403-8. PubMed ID: 15008870
[TBL] [Abstract][Full Text] [Related]
18. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol.
Cherpelis BS; Moore R; Ladd S; Chen R; Glass LF
Dermatol Surg; 2009 Feb; 35(2):207-13. PubMed ID: 19215257
[TBL] [Abstract][Full Text] [Related]
19. The perineural corona sign: enhancing detection of perineural squamous cell carcinoma during Mohs micrographic surgery with toluidine blue stain.
Drosou A; Trieu D; Goldberg LH; Kimyai-Asadi A
J Am Acad Dermatol; 2014 Oct; 71(4):826-7. PubMed ID: 25219703
[No Abstract] [Full Text] [Related]
20. Mohs micrographic surgery for the treatment of melanoma.
Hui AM; Jacobson M; Markowitz O; Brooks NA; Siegel DM
Dermatol Clin; 2012 Jul; 30(3):503-15. PubMed ID: 22800554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
